These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1864563)

  • 1. Triiodothyronine antibodies in a case of Graves' disease: long-term follow-up under carbimazole.
    Heshmati HM; Izembart M; Turpin G; Vallée G
    Horm Metab Res; 1991 Mar; 23(3):148. PubMed ID: 1864563
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-triiodothyronine antibodies in Basedow's disease treated with carbimazole].
    Heshmati HM; Izembart M; Turpin G; Vallée G
    Presse Med; 1989 Dec 16-23; 18(42):2066. PubMed ID: 2532348
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of remission after antithyroid drug treatment in Graves' disease.
    Young ET; Steel NR; Taylor JJ; Stephenson AM; Stratton A; Holcombe M; Kendall-Taylor P
    Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunosuppressive action of carbimazole and propylthiouracil.
    Wilson R; McKillop JH; Pearson C; Burnett AK; Thomson JA
    Clin Exp Immunol; 1988 Aug; 73(2):312-5. PubMed ID: 3263234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission.
    Peakman M; Hussain M; Cundy T; Vergani D
    J Clin Lab Immunol; 1989 Sep; 30(1):1-5. PubMed ID: 2577115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the relationship between labelled triiodothyronine and thyroxine levels in the serum of patients with Graves' disease.
    Földes J; Gyertyánfy G; Tako J; Bános C; Gesztesi E
    Endokrinologie; 1973 Jan; 61(1):52-64. PubMed ID: 4739850
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of autoimmunity in Graves' disease before and after treatment with carbimazole.
    Zosin I; Arcan P; Lungu G; Cotoi A; Opreanu R
    Endocrinologie; 1988; 26(1):49-53. PubMed ID: 3260398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasmatic thyroid hormones during treatment of hyperthyroidism by carbimazol (author's transl)].
    Linquette M; Lefebvre J; Benoit G; Racadot A
    Ann Endocrinol (Paris); 1977; 38(2):169-70. PubMed ID: 578398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism.
    Verhoeven RP; Visser TJ; Doctor R; Hennemann G; Schalekamp MA
    J Clin Endocrinol Metab; 1977 May; 44(5):1002-5. PubMed ID: 576870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unusual concentrations of triiodothyronine in the serum due to anti-T3 autoantibodies].
    Savoie JC; Thomas G; Gayno JP; Laurent MF; Savoie F; Leger AF
    Nouv Presse Med; 1982 Dec; 11(51):3783-6. PubMed ID: 6897565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of thyroxine thyrotoxicosis.
    Blank MS; Tucci JR
    Arch Intern Med; 1987 May; 147(5):863-4. PubMed ID: 3579439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of anti-TSH receptor antibodies (TRAb) to predict the outcome of the course of Graves' disease following withdrawal of antithyroid drug.
    Shoda Y; Akiyama H; Yamaguchi T; Inukai T; Kobayashi I; Kondo Y; Kobayashi S
    Exp Clin Endocrinol; 1991 Mar; 97(1):113-6. PubMed ID: 1677893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of outcome in Graves' disease after carbimazole treatment.
    Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
    Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.
    Wilson R; McKillop JH; Pearson C; Burnett AK; Gunn I; McNicol AM; Thomson JA
    Clin Exp Immunol; 1988 Aug; 73(2):265-8. PubMed ID: 3263232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin autoantibodies in Graves' disease--before and after carbimazole therapy.
    Armitage M; Franklyn J; Scott-Morgan L; Parr J; Borsey DQ; Sheppard M; Wilkin TJ
    Diabetes Res Clin Pract; 1990 Mar; 8(3):169-76. PubMed ID: 2340791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation of thyrotrophin secretion by exogenous thyroxine and triiodothyronine.
    Yeo PP; Lewis M; Davies TF; Weightman DR; Marshall J; Ratcliffe JG; Evered DC
    Clin Chim Acta; 1979 Dec; 99(3):203-10. PubMed ID: 583260
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and significance of steatorrhea in patients with active Graves' disease.
    Goswami R; Tandon RK; Dudha A; Kochupillai N
    Am J Gastroenterol; 1998 Jul; 93(7):1122-5. PubMed ID: 9672342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of the E-rosette as a test for remission in Graves' disease treated with antithyroid drugs.
    Farid NR; Munro R; Row VV; Volpé R
    Clin Endocrinol (Oxf); 1974 Jan; 3(1):55-61. PubMed ID: 4407296
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I; Balázs C
    Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.